Rosie Cooke

Rosie Cooke


Are you Rosie Cooke?   Register this Author

Register author
Rosie Cooke

Rosie Cooke

Publications by authors named "Rosie Cooke"

Are you Rosie Cooke?   Register this Author



Retrospective methods to estimate radiation dose at the site of breast cancer development after Hodgkin lymphoma radiotherapy.

Clin Transl Radiat Oncol 2017 Dec 24;7:20-27. Epub 2017 Oct 24.

Divison of Psychosocial Research, Epidemiology and Biostatistics, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, The Netherlands.

View Article
December 2017

Genome-wide homozygosity signature and risk of Hodgkin lymphoma.

Sci Rep 2015 Sep 22;5:14315. Epub 2015 Sep 22.

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.

View Article
September 2015

Effects of single-agent and combination chemotherapy for gestational trophoblastic tumors on risks of second malignancy and early menopause.

J Clin Oncol 2015 Feb 29;33(5):472-8. Epub 2014 Dec 29.

Philip Savage, Jenny O'Nions, Jon Krell, Amy Kwan, Michelle Camarata, Gairin Dancy, Dee Short, and Michael J. Seckl, Charing Cross Hospital, Imperial Hospitals National Health Service Trust, London; and Rosie Cooke and Anthony Swerdlow, Institute of Cancer Research, Sutton, Surrey, United Kingdom.

View Article
February 2015

Risk of premature menopause after treatment for Hodgkin's lymphoma.

J Natl Cancer Inst 2014 Sep 19;106(9). Epub 2014 Aug 19.

Divisions of Genetics and Epidemiology (AJS, RC), Breast Cancer Research (AJS) and Radiotherapy (AH), Institute of Cancer Research, Sutton, UK; University of Manchester and Christie NHS Foundation Trust, Manchester, UK (JR); Gastrointestinal Unit, Royal Marsden Hospital, Sutton, UK (DC); Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK (IS); Cancer Research UK Medical Oncology Unit, St. Bartholomew's Hospital, London, UK (TAL); Cancer Centre, Mount Vernon Hospital, Middlesex, UK (PJH); St. James Institute of Oncology, Leeds, UK (DG); Northern Centre for Cancer Care, Freeman Hospital, Newcastle, UK (HHL); Bristol Haematology and Oncology Centre, Bristol, UK (SJF); Addenbrooke's Hospital, Cambridge, UK (MVW); Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK (BWH); Guy's and St. Thomas, London, UK (SJH); Department of Haematology, University College Hospital, London, UK (DCL); Southampton General Hospital, Southampton, UK (AB); Queen Elizabeth Hospital, Birmingham, UK (AMS). The England and Wales Hodgkin Lymphoma Follow-up Group includes the authors of this article plus: Gabriel Anghel, Lincoln Hospital; Brian Attock, North Devon District Hospital; Jane Barrett, Royal Berkshire Hospital; Andrew Bell, Poole Hospital; Kim Benstead, Cheltenham General Hospital; Eric M. Bessell, Nottingham University Hospital; Ashoke Biswas, Royal Preston Hospital; Norbert Blesing, Great Western Hospital, Swindon; Caroline Brammer, New Cross Hospital, Wolverhampton; Jill Brock, Clatterbridge Centre for Oncology; Alison Brownell, Queens Hospital, Romford; A. Murray Brunt, University Hospital of North Staffordshire; Peter B. Coates, Queen Elizabeth Hospital, King's Lynn; Matthew P. Collinson, Royal Cornwall Hospital; Neville Davidson, Essex County Hospital; Sian Davies, North Middlesex University Hospital; Ian Fentiman, Guy's Hospital; Eve Gallop-Evans, Velindre Hospital; Angel Garcia, Glan Clwyd Hospital; Andrew Goodman, Royal Devon and Exeter Hospital; Ad

View Article
September 2014

Radiologic features of breast cancer after mantle radiation therapy for Hodgkin disease: a study of 230 cases.

Radiology 2014 Jul 25;272(1):73-8. Epub 2014 Mar 25.

From the Department of Radiology, Royal Marsden NHS Foundation Trust, Downs Rd, Sutton, Surrey SM2 5PT, England (S.D.A.); Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, Cambridgeshire, England (M.G.W.); and Divisions of Genetics and Epidemiology (R.C., A.J.S.) and Breast Cancer Research (A.J.S.), Institute of Cancer Research, Sutton, Surrey, England.

View Article
July 2014

Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results.

J Natl Cancer Inst 2014 Mar 19;106(3):djt465. Epub 2014 Feb 19.

Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD (LAB, MBC, RTF, JHL); Section on Environment and Radiation, International Agency for Research on Cancer, Lyon, France (VM); Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada (KCJ); Department of Oncology, Lund University, Lund, Sweden (HO); Department of Preventive Medicine, University of Southern California, Los Angeles, CA (JTC, BEH, MCP, GU); Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, UK (RC, AJS); Epidemiology Research Program, American Cancer Society, Atlanta, GA (SMG, MMG); Department of Medicine (JMG), Obstetrics and Gynecology Epidemiology Center, Department of Obstetrics, Gynecology and Reproductive Biology (KBM), and Divisions of Preventive Medicine and Aging (HDS), Brigham and Women's Hospital, Boston, MA; MAVERIC, VA Boston Healthcare System, Boston, MA (JMG); Department of Surgery, Aretaieion University Hospital, Athens, Greece (GG); Center for Research in Epidemiology and Population Health, INSERM Unit 1018, Paris-Sud University, Villejuif, France (PG); AARP Research, AARP, Washington, DC (AH); Cancer Prevention Institute of California, Freemont, CA (AWH); Division of Epidemiology, Department of Health Research and Policy, and Stanford Cancer Institute, Stanford School of Medicine, Stanford University, Palo Alto, CA (AWH); Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI (LNK); Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC (CI); Department of Epidemiology (KBM) and Department of Nutrition (WCW), Harvard School of Public Health, Boston, MA (KBM); Istituto di Richerche Farmacologiche, Milan, Italy (EN, DT); IMS, Inc, Rockville, MD (DP, KS); Department of Hygiene, Epidemiology and Medical Statistics, Athens University Medical School, Athens, Greece (ETP); School of Public Health, Imperial C

View Article
March 2014

FGFR2 genotype and risk of radiation-associated breast cancer in Hodgkin lymphoma.

Blood 2012 Jan 5;119(4):1029-31. Epub 2011 Dec 5.

Section of Cancer Genetics, Institute of Cancer Research, 15 Cotswold Rd., Sutton, Surrey, United Kingdom.

View Article
January 2012

Genetic variants at chromosomes 2q35, 5p12, 6q25.1, 10q26.13, and 16q12.1 influence the risk of breast cancer in men.

PLoS Genet 2011 Sep 15;7(9):e1002290. Epub 2011 Sep 15.

The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.

View Article
September 2011

IRF4 polymorphism rs872071 and risk of Hodgkin lymphoma.

Br J Haematol 2010 Feb 5;148(3):413-5. Epub 2009 Oct 5.

Section of Cancer Genetics, Institute of Cancer Research, Royal Marsden Hospitals NHS Trust, London, UK.

View Article
February 2010